| Amphetamine | 🇺🇸États-Unis | 12.5MG BASE, 15.7MG BASE, 18.8MG BASE … | tablet, orally disintegrating, extended release | Commercialisé | Actavis Labs FL INC |
| Amphetamine Sulfate | 🇺🇸États-Unis | 10MG, 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 5MG … | tablet | Commercialisé | Granules |
| Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate and Amp SulfateAssociation | 🇺🇸États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 1.875MG; 1.875MG; 1.875MG; 1.875MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG … | tablet | Commercialisé | Actavis Elizabeth |
| Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate and Amp SulfateAssociation | 🇺🇸États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 12.5MG; 12.5MG; 12.5MG; 12.5MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG … | capsule, extended release | Commercialisé | Ani Pharms |
| Adderall XR 5Association | 🇺🇸États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 10Association | 🇺🇸États-Unis | 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 15Association | 🇺🇸États-Unis | 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 20Association | 🇺🇸États-Unis | 5MG; 5MG; 5MG; 5MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 25Association | 🇺🇸États-Unis | 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 30Association | 🇺🇸États-Unis | 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adzenys XR-ODT | 🇺🇸États-Unis | 12.5MG BASE, 15.7MG BASE, 18.8MG BASE … | tablet, orally disintegrating, extended release | Commercialisé | Neos Theraps |
| Dyanavel XRAssociation | 🇺🇸États-Unis | 2MG/ML; 0.5MG BASE/ML | suspension, extended release | Commercialisé | Tris Pharma INC |
| Dyanavel XR 10Association | 🇺🇸États-Unis | 8MG; 2MG BASE | tablet, extended release | Commercialisé | Tris Pharma INC |
| Dyanavel XR 15Association | 🇺🇸États-Unis | 12MG; 3MG BASE | tablet, extended release | Commercialisé | Tris Pharma INC |
| Dyanavel XR 20Association | 🇺🇸États-Unis | 16MG; 4MG BASE | tablet, extended release | Commercialisé | Tris Pharma INC |
| Dyanavel XR 5Association | 🇺🇸États-Unis | 4MG; 1MG BASE | tablet, extended release | Commercialisé | Tris Pharma INC |
| Evekeo | 🇺🇸États-Unis | 10MG, 5MG | tablet | Commercialisé | Azurity |
| MydayisAssociation | 🇺🇸États-Unis | 12.5MG; 12.5MG; 12.5MG; 12.5MG, 3.125MG; 3.125MG; 3.125MG; 3.125MG, 6.25MG; 6.25MG; 6.25MG; 6.25MG … | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Amphetamine | 🇺🇸États-Unis | 10MG, 15MG, 20MG | tablet, extended release | Approbation provisoire | Granules Pharmaceuticals INC |
| Amphetamine | 🇺🇸États-Unis | 12.5MG, 15.7MG, 18.8MG … | tablet, orally disintegrating | Approbation provisoire | Granules Pharmaceuticals INC |
| Benzedrine | 🇺🇸États-Unis | 10MG, 5MG | Tablet | Non commercialisé | Smith Kline & French |
| Adderall 5Association | 🇺🇸États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adzenys ER | 🇺🇸États-Unis | 1.25MG BASE/ML | suspension, extended release | Non commercialisé | Neos Theraps INC |
| Adderall 10Association | 🇺🇸États-Unis | 2.5MG; 2.5MG; 2.5MG; 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 15Association | 🇺🇸États-Unis | 3.75MG; 3.75MG; 3.75MG; 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
